Unicycive Therapeutics, Inc. · NASDAQ:UNCY
Nantahala Capital Management, LLC reported a 9.99% stake in Unicycive Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Nantahala Capital Management, LLC reported a 9.99% stake in Unicycive Therapeutics, Inc., 2,807,830 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 2,807,830
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 9.99% | 2,807,830 |
| Wilmot B. Harkey | 9.99% | 2,807,830 |
| Daniel Mack | 9.99% | 2,807,830 |
Source
Related
- Unicycive Therapeutics, Inc.
- Nantahala Capital Management, LLC
- Unicycive Therapeutics, Inc. shareholders
- Schedule 13G/A · Nantahala Capital Management, LLC · Feb 13, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 8, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · May 15, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Feb 17, 2026